Abstract
A placebo response refers to the improvement in a patient's clinical symptoms when administered with an inert substance, whereas a nocebo response is the worsening of clinical symptoms. The neuropeptide oxytocin is implicated in social trust, stress/anxiety, and learning processes that also contribute to placebo and nocebo responses. This leads to an intriguing hypothesis that pharmacological manipulation of oxytocin 1nay modulate placebo/nocebo. It has been proposed that oxytocin may enhance social trust, a key element of the patient-doctor relationship, which may further boost placebo effects. Oxytocin has also been shown to be involved in reducing stress and anxiety, which might contribute significantly to the magnitude of nocebo.
Original language | English |
---|---|
Pages (from-to) | 185-187 |
Number of pages | 3 |
Journal | Psychotherapy and Psychosomatics |
Volume | 89 |
Issue number | 3 |
Early online date | 20 Dec 2019 |
DOIs | |
Publication status | Published - May 2020 |
Externally published | Yes |
Funding
This work was supported by the Natural Scientific Foundation of China (No. 81771186).